No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey

Detalles Bibliográficos
Autores principales: Hamada, Eriko, Sakai, Kazuya, Yamada, Shinya, Kubo, Masayuki, Hayakawa, Masaki, Matsumoto, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814789/
https://www.ncbi.nlm.nih.gov/pubmed/35119501
http://dx.doi.org/10.1007/s00277-022-04774-2
_version_ 1784645140310130688
author Hamada, Eriko
Sakai, Kazuya
Yamada, Shinya
Kubo, Masayuki
Hayakawa, Masaki
Matsumoto, Masanori
author_facet Hamada, Eriko
Sakai, Kazuya
Yamada, Shinya
Kubo, Masayuki
Hayakawa, Masaki
Matsumoto, Masanori
author_sort Hamada, Eriko
collection PubMed
description
format Online
Article
Text
id pubmed-8814789
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-88147892022-02-04 No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey Hamada, Eriko Sakai, Kazuya Yamada, Shinya Kubo, Masayuki Hayakawa, Masaki Matsumoto, Masanori Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2022-02-04 2022 /pmc/articles/PMC8814789/ /pubmed/35119501 http://dx.doi.org/10.1007/s00277-022-04774-2 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Hamada, Eriko
Sakai, Kazuya
Yamada, Shinya
Kubo, Masayuki
Hayakawa, Masaki
Matsumoto, Masanori
No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey
title No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey
title_full No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey
title_fullStr No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey
title_full_unstemmed No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey
title_short No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey
title_sort no aggravation of congenital thrombotic thrombocytopenic purpura by mrna-based vaccines against covid-19: a japanese registry survey
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814789/
https://www.ncbi.nlm.nih.gov/pubmed/35119501
http://dx.doi.org/10.1007/s00277-022-04774-2
work_keys_str_mv AT hamadaeriko noaggravationofcongenitalthromboticthrombocytopenicpurpurabymrnabasedvaccinesagainstcovid19ajapaneseregistrysurvey
AT sakaikazuya noaggravationofcongenitalthromboticthrombocytopenicpurpurabymrnabasedvaccinesagainstcovid19ajapaneseregistrysurvey
AT yamadashinya noaggravationofcongenitalthromboticthrombocytopenicpurpurabymrnabasedvaccinesagainstcovid19ajapaneseregistrysurvey
AT kubomasayuki noaggravationofcongenitalthromboticthrombocytopenicpurpurabymrnabasedvaccinesagainstcovid19ajapaneseregistrysurvey
AT hayakawamasaki noaggravationofcongenitalthromboticthrombocytopenicpurpurabymrnabasedvaccinesagainstcovid19ajapaneseregistrysurvey
AT matsumotomasanori noaggravationofcongenitalthromboticthrombocytopenicpurpurabymrnabasedvaccinesagainstcovid19ajapaneseregistrysurvey

Ejemplares similares